Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test Clinical Performance Study

NCT05618561 is registered in ClinicalTrials.gov with AnteoTech Ltd as lead sponsor.

NCT NCT05618561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test Clinical Performance Study
Lead sponsor
AnteoTech Ltd
Phase
Observational
Overall status
Terminated
Start date
July 26, 2022
Completion date
November 2, 2022
Enrollment
599 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection